ExamWorks Group Beats on the Top Line
ExamWorks Group (NYS: EXAM) reported earnings on May 9. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended March 31 (Q1), ExamWorks Group beat expectations on revenues and missed expectations on earnings per share.
Compared with the prior-year quarter, revenue grew significantly and GAAP loss per share expanded.
Margins contracted across the board.
ExamWorks Group booked revenue of $123.7 million. The three analysts polled by S&P Capital IQ expected net sales of $117.7 million on the same basis. GAAP reported sales were 86% higher than the prior-year quarter's $66.6 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at -$0.13. The four earnings estimates compiled by S&P Capital IQ forecast -$0.11 per share. GAAP EPS were -$0.13 for Q1 against -$0.02 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 34.4%, 20 basis points worse than the prior-year quarter. Operating margin was -0.1%, 140 basis points worse than the prior-year quarter. Net margin was -3.5%, 270 basis points worse than the prior-year quarter.
Next quarter's average estimate for revenue is $124.9 million. On the bottom line, the average EPS estimate is -$0.08.
Next year's average estimate for revenue is $515.6 million. The average EPS estimate is -$0.37.
The stock has a one-star rating (out of five) at Motley Fool CAPS, with 12 members out of 19 rating the stock outperform, and seven members rating it underperform. Among six CAPS All-Star picks (recommendations by the highest-ranked CAPS members), four give ExamWorks Group a green thumbs-up, and two give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on ExamWorks Group is outperform, with an average price target of $12.75.
If you're interested in health-care stocks like ExamWorks Group, you might want to expand your horizons to find maximum returns. Follow the money and meet a prime candidate for major returns in our new report, "Discover the Next Rule-Breaking Multibagger." Get instant access to this free report.
- Add ExamWorks Group to My Watchlist.
At the time this article was published Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings. He is the co-advisor ofMotley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.